BLUECHIP INVESTMENTS WEEKLY Deepotsvai
BLUECHIP INVESTMENTS WEEKLY Deepotsvai
SINCE 1992
32 Anniv
ersary
In the
Golden Period of Samvat 2081
continue from previous page of Lalbhai Group in 1985-86. The company is one of the
largest manufacturers and exporters of dye-intermedi-
Simplex Castings Limited: ates in the country. The company has implemented var-
BSE (513472), NSE (SIMPLEXCAS) Listed, Rs.10 Paid-Up SIMPLEX ious projects including a multi-purpose modern EOU
CASTINGS LIMITED Cast Aryan Foundry, Steel & Alloy Foundry, for manufacturing bulk drugs in Pardi, Gujarat. In the
Fabrication Plant for Heavy Engineering & Equipment Manufacturing, year 2020-21, a wholly owned subsidiary of the compa-
Structural Fabrication, Assembly Facilities Has ny, Amal Specialty Chemicals, has been started. The share is currently
manufacturing facilities. The company has a glob- fetching close to Rs.375.
al presence in core sector industries like steel
mills, aluminium smelters and downstream, other
Gujarat Pipavav Port Limited:
metallurgical plants, railways, power plants, valves BSE (533248), NSE (GPPL) Listed, Rs.10 Paid-up, GUJARAT PIPAVAV
and pump industries, mining, cement, sugar, PORT LIMITED (GUJARAT PIPAVAV PORT LIMITED) Formerly known as
heavy earth movers, HMM, material handling, oil APM Terminals Pipavav, Pipavav Port is located in
& Approved and Registered Supply Partner for Gas, Defence, Chemical Gujarat, just 152 nautical miles from Nhawa Sheva in
Plants etc. The share is currently fetching close to Rs.315. Mumbai ( 10 hours steaming time). It has immediate
accessibility by road and rail to major markets in
Gandhar Oil Refineries Limited: North-West India and India's largest seafood export
BSE (544029), NSE (GANDHAR) Listed, Rs.2 paid-up, GANDHAR OIL belt. The port is operated by APM Terminals (shareholding 44.1 per-
REFINERY INDIA LIMITED is well known in the world of specialty oil. The cent). APM Terminals Pipavav currently has the capacity to handle 13.5
company is engaged in manufacturing of Crore TEU containers, 40 - 50 lakh tonnes of dry bulk cargo, 2 million
white oil with focus on its customers and tonnes of liquid cargo and around 250,000 cars per year. The share is
healthcare and industries. The company has getting close to Rs.190.
more than 3558 diversified customers. The
company manufactures a variety of specialty oils and lubricants such as
Poonawalla Fincorp Limited:
white oil, wax, jelly, automotive oil, industrial oil, transformer oil and BSE (524000), NSE (POONAWALLA) Listed, Rs.2 paid-up formerly
rubber processing oil. The company has three decades of experience in known as Magma Fincorp Limited and renamed as POONAWALLA FIN-
the specialty oil industry. The company having Taloja plant along with CORP LIMITED in July 2021 after acquisition, the company is a non-
Silvassa plant has expanded to UAE and has Taxol subsidiary unit. The banking finance company of the Cyrus-
share is currently fetching close to Rs.220. Poonawalla Group. , which focuses on con-
sumer and MSME lending. The company offers
Piramal Pharma Limited: a diverse suite of products to meet the growing
BSE (543635), NSE (PPLPHARMA) Listed, Rs.10 paid-up, PIRAMAL credit needs of consumers and enterprises. The company offers per-
PHARMA LIMITED offers a diverse portfolio of products and services sonal loans, business loans, and professional loans, pre-owned car
through its global development and manufacturing facilities as well as loans, loans against property, medical equipment loans and machinery
a distribution network in over 100 countries. loans. The company has recently made a positive provision in its quar-
Piramal Pharma Limited comprises Piramal terly results to clear the balance sheet by making a provision of Rs.666
Pharma Solutions (PPS) an integrated contract Crore to cover possible losses in the short term personal loan portfolio.
development and manufacturing organization The share is getting close to Rs.295.
Piramal Critical Care (PCC), a complex hospital
generics business. Along with this, the India Consumer Healthcare busi-
Western Carriers India Limited:
ness sells over-the-counter products. Apart from this, ABBV BSE (544258), NSE (WCIL) Listed, Rs.5 paid-up, WESTERN CARRIERS
Therapeutics India Limited, one of PPL's associate companies, is ABBV INDIA LIMITED, India's largest private, multi-modal, rail-focused carrier
Inc. has a joint venture with and has emerged as a market leader in the by container volume controlled by the country's private sector. FourPL
field of ophthalmology. The share is currently fetching close to Rs.240. is an asset light logistics company. The company's market share based
on container volume is 6 percent in the domestic mar-
ITC Limited: ket and 2 percent in the EXIM market as of FY2023. The
BSE (500875), NSE (ITC) Listed Rs.1 paid-up, ITC LIMITED is one of company has many years of experience in multi-modal
India's leading private sector companies with businesses spanning Fast movement by road, rail and sea for domestic as well as
Moving Consumer Goods, Hotels, Paperboards and EXIM cargoes in India and abroad. The company has
Packaging, Agri Business, Information Technology There is clients including Balco, Jindal Stainless, Vedanta, Hindalco, Signode,
also a diverse group. The company is recognized as one of Tata, Sheela Group, Gujarat Heavy Chemical, MCPL, Cipla. Recently, the
India's most valuable business corporations with a net profit company has allotted shares in IPO at a price of Rs.172. The share is cur-
of Rs.20, 422 Crore on revenue of Rs.69, 446 Crore for the year rently fetching close to Rs.125. For those considering investments in
ended March 31, 2024. The hotel business of the company is Samvat 2081, here are some noteworthy stocks across diverse sectors
being demerged. The company has received approval from the Kolkata that could offer promising returns. Below is a breakdown of each com-
bench of the National Company Law Tribunal. For every 10 shares of ITC pany along with its latest share price, highlighting potential areas of
Limited, one share of ITC Hotels will be allotted. The expected demerg- growth and industry presence.
er of more businesses including IT from ITC Limited is a value unlocking Company Name Share Price
candidate. The share is currently fetching close to Rs.475. Jio Financial Services Ltd. Rs.305, Tata Technologies Ltd. Rs.1000
Amal Limited: Simplex Castings Ltd. Rs.315
Gandhar Oil Refinery Ltd. Rs.220
Only BSE (506597) listed AMAL LIMITED is engaged in the manufac- Piramal Pharma Ltd. Rs.240 ITC Ltd. Rs.475
ture and sale of bulk chemicals such as sulphuric acid and oleum and Amal Limited Rs.375 Gujarat Pipavav Port Ltd. Rs.190
its downstream products such as sulphur dioxide and sulphur trioxide. These stocks represent a diverse mix of industries, from finance to
Its plant is in Ankleshwar-Gujarat. The controlling holding in the com- pharmaceuticals, and provide options to investors with different risk
pany promoted by Piramal Group in 1974-75 was sold to Atul Limited appetites and investment goals.
SINCE 1992
DEEPOTSAVI ISSUE
04 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
05 BLUECHIP INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
continue from previous page products, pre-engineered buildings, steel automotive, railways, and logistics.
4. Risks products, and systems catering to sectors like Export Opportunities: The company has
Regulatory Challenges: The financial railways, infrastructure, and automotive. been growing its export business, especially in
services sector in India is highly regulated. Any Market Position: Pennar has established a markets like the U.S. and Europe, which offers
unfavorable regulatory changes could impact strong presence in India, known for quality a stable revenue stream and reduces depend-
JFS's growth trajectory. engineering solutions, and has a diverse cus- ency on domestic demand.
Intense Competition: JFS faces competi- tomer base across multiple industries, which 4. Risks
tion from established banks and other fintech helps mitigate sector-specific risks. Raw Material Cost Fluctuations: Steel
companies. Competitors with mature technol- 2. Financial Performance and other metal prices impact Pennar's prof-
ogy and operational models could pose chal- Revenue Growth: Pennar has shown a itability. Price increases that cannot be passed
lenges as JFS builds its customer base. steady increase in revenues, driven by on to customers may squeeze margins.
Execution Risks: As a new entrant in finan- demand from the infrastructure, automotive, Project Execution: Delays in large-scale
cial services, JFS's ability to scale and execute and railway sectors. The company's focus on infrastructure projects, either due to economic
its ambitious plans effectively will be key. value-added products and increasing or regulatory challenges, can impact demand
Delays in execution or integration could exports has also positively impacted revenue for Pennar's engineering products and pre-
impact near-term results. growth. engineered buildings.
5. Valuation Profit Margins: Pennar maintains stable Competitive Landscape: Pennar faces
Current CMP: Rs. 311 operating and net profit margins, though they competition from both domestic and interna-
Target Price: Rs. 400-Rs. 430 can be sensitive to fluctuations in raw material tional players, particularly in its key markets.
Conclusion prices. However, the company's focus on cost Pricing pressures in the engineering sector can
Jio Financial Services has significant growth optimization and value-added products helps impact profitability.
potential due to its affiliation with Reliance it maintain competitive margins. 5. Valuation
and its strategic position in the fast-growing Debt and Cash Flow: Pennar has been Current CMP: Rs. 185 :
digital financial services market. With an actively working to manage its debt levels, Target Price: Rs. 245-Rs. 255
expected upside of approximately 29-38%, JFS which has improved its balance sheet health. Conclusion
offers an attractive investment case, especially Positive cash flow from operations indicates With its diversified product range, growing
for long-term investors looking for exposure that it has adequate liquidity to support exports, and alignment with India's infrastruc-
to India's digital financial boom. However, expansion plans without excessive leverage. ture and industrial growth, Pennar Industries
close monitoring of its execution, regulatory 3. Growth Drivers has solid growth potential. Based on the target
environment, and the competitive landscape is Infrastructure Development: Government price, there's an expected upside of approxi-
essential as the company establishes its pres- initiatives like 'Make in India' and infrastructure mately 32-38%, making it a promising invest-
ence in this sector. investments benefit Pennar by driving demand ment. However, potential investors should
for its products, especially in the construction remain aware of raw material volatility and
Pennar Industries Ltd. and railways segments. infrastructure project risks, which can impact
1. Company Overview Diversified Product Portfolio: Pennar's short-term results. Long-term, Pennar's growth
Industry: Pennar Industries operates in the diversified offerings, from engineering compo- outlook remains strong due to favorable
engineering sector, with a diversified product nents to pre-engineered buildings, help it cap- macroeconomic conditions and its well-diver-
portfolio including precision engineering ture growth across multiple sectors, including sified portfolio.
Disclaimer: This analysis is based on current market data and is subject to change as new information becomes available.
Zanil Shah - SEBI Registered RA Investors should conduct their own research and consult with financial advisors before making any investment decisions.
NIFTY
BANK NIFTY
As the festival of lights ushers in a new year, we extend warm wish- possible toward their 21-week averages, any sustained close below
es for happiness, health, wealth, and prosperity to all. Wishing the 50-week average could indicate further correction over the short
everyone a very Happy Diwali and a prosperous New Year! to medium term.
Nifty's recent downturn continued, with the index dipping to Diwali Stock Picks for the Next Year: Technical Analysis
24,068 as it breached the crucial 24,800 support. This week alone, As we step into the New Year, here are a few stock insights for
Nifty lost 3%, accumulating an 8.8% drop from its peak of 26,402. potential investments over the coming year:
Based on previous projections, a 10% correction could take Nifty CUB (City Union Bank):
down to 23,800, with potential further support levels at 23,430 and Currently trading
23,074 if selling pressure persists. For any recovery, Nifty would need around Rs. 171, this
to reclaim 24,600, opening the way for resistance at 24,900 and stock appears posi-
25,200. tive on the weekly
Bank Nifty Performance and Key Levels chart, holding above
Bank Nifty mirrored Nifty's weakness after it broke the head-and- both short-term and
shoulders neckline last week, testing a low of 50,374 before closing at long-term moving
50,846. Sustaining below the 50,375 level could lead Bank Nifty averages. It may be
toward 49,870, 49,540 (its 200-day SMA), and possibly 46,500. On the worth accumulating
upside, targets lie at 51,598 and 52,098, with a more optimistic out- on dips, with poten-
look only if it can decisively break above 52,098. tial targets at Rs. 215, Rs. 275, Rs. 311, and Rs. 370 in the longer term.
Sectoral Indices Weekly Review Setting a stop loss is advised based on individual risk tolerance.
With the broader market turning negative, here's a look at sectoral DYCL: Near its all-
indices: time high at Rs. 656,
Nifty Midcap: The weekly chart shows Nifty Midcap breaking its DYCL presents a medi-
March 2023 trend- um to long-term out-
line, though it look with potential tar-
remains above its gets at Rs. 798, Rs.
longer trendline 1,084, and Rs. 1,260.
from March 2020. In accumulate on dips,
the short to medi- keeping a stop loss suit-
um term, the index ed to your risk appetite.
appears weak and Sona Comstar: The
could test levels of stock bounced back
51,987 and 47,250. strongly from its 50-
Nifty Smallcap: week moving average
The Smallcap index on Friday with high vol-
recently saw signifi- umes. Consider accu-
cant growth but has mulating on dips, tar-
now turned nega- geting levels of Rs. 760,
tive on the weekly Rs. 882, and Rs. 1,078.
chart. This index
may test levels of Tata Chemicals: After an
16,750 and 15,000 extended period of consoli-
in the short to dation, Tata Chemicals is
medium term. trading near its weekly trend-
Sector Outlook: Key Support and Potential Rebound line support. Accumulating
Major sectoral indices, including Nifty Metal, Pharma, Oil & Gas, on dips could yield targets at
Infra, and Energy, are currently near their 50-week averages, suggest- Rs. 1,200, Rs. 1,375, Rs. 1,640,
ing they're trading around support levels. While some rebound is and Rs. 1,810.
SINCE 1992
DEEPOTSAVI ISSUE
11 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
12 BLUECHIP INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
continue from previous page short-term investment strategies. Wipro's strategic focus on securing larger proj-
opportunity for those looking to capitalize on Dr.Reddy's Market Update : Dr. Reddy's ects and expanding its service offerings posi-
the expanding Indian market. Laboratories is a prominent player in the phar- tions the company for robust revenue growth
FCS Software Market Update: Currently maceutical sector, known for its comprehensive and improved profit margins. With a commit-
trading at 3.30, FCS Software has notable upside range of generic medications, APIs, and propri- ment to innovation and digital transformation,
potential, targeting 9 by next Diwali. As a small- etary products. Currently trading at around Rs. Wipro remains a strong contender in the IT sec-
cap IT company, it is experiencing consistent 6700, the stock is expected to grow to approxi- tor, making it an attractive option for investors
revenue growth, which positions it well for mately Rs. 7600 over the next year, driven by looking to add quality stocks to their portfolios.
future appreciation. With its expanding business strong sales in both domestic and international Gold Market Update :
and positive market outlook, FCS Software's markets, ongoing product launches, and strate- Gold is currently trading at Rs. 78,000, with a
stock price could reach new highs this year, gic acquisitions. With a commitment to innova- projected growth to around Rs. 87,700 over the
making it an intriguing option for investors tion and quality, Dr. Reddy's is well-positioned next year. Year-to-date, gold has seen an
seeking opportunities in the tech sector. for sustainable growth. This makes it an attrac- impressive increase of approximately 26%.
Yes Bank Market Update: Currently trading tive addition to investment portfolios, appeal- While the momentum may slow compared to
at 21, Yes Bank has significant upside potential, ing to both long-term and short-term investors previous surges, the overall outlook remains
targeting 180 by Diwali 2026. Recent news indi- in the pharma space. positive, driven by ongoing economic uncer-
cates strong interest from various international Idea Market Update : Idea Cellular tainties and inflationary pressures. By the next
investors looking to acquire stakes in the bank, (Vodafone Idea) is currently trading at Rs. 8.50, Diwali, we can expect an uptrend, with a poten-
which could boost its valuation. With potential with potential for significant upside, projected tial return of around 12% over the next year. As
for substantial growth, Yes Bank is positioning to reach Rs. 26 within the next year. The recent a safe-haven asset, gold continues to be a valu-
itself as a promising multibagger stock in the fundraising efforts position the company to able addition to investment portfolios, particu-
coming years, making it an attractive option for enhance its 4G network and introduce 5G serv- larly in times of market volatility.
investors. ices, aiming to attract more users and improve Silver Market Update : Silver is currently
ITC Market Update : ITC Limited is a diver- market competitiveness. Although the stock has trading at Rs. 98,000, with a projected growth
sified conglomerate with strong foundations in experienced a downturn in the past two potential reaching Rs. 113,000 within the next
the FMCG sector, contributing significantly to its months, this may provide a strong support level year. The metal has seen a notable increase of
growth potential. Currently trading at around for potential buyers. While investing in Idea around 30% year-to-date. Although momen-
Rs. 480, analysts project that the stock could comes with higher risks, the potential rewards tum may slow compared to previous gains, the
reach levels of Rs. 660 over the next year, driven could be substantial, making it an intriguing outlook remains positive, driven by rising
by robust demand for its consumer products, option for aggressive investors looking to add demand from manufacturing sectors and indus-
expansion in new categories, and efficient cost high-reward opportunities to their portfolios. trial applications. As we approach next Diwali,
management. ITC's strong brand portfolio and TataMotors Market Update : Tata Motors is silver is expected to continue its upward trend,
sustainability initiatives further enhance its a leading player in the automotive sector, cur- with anticipated returns of about 15% over the
appeal as a top choice for long-term investors. rently trading at Rs. 880, with a promising next year. Given its industrial utility alongside its
With its steady revenue streams and consistent growth trajectory projected to reach Rs. 1600 status as a precious metal, silver presents a
dividend payouts, ITC remains a solid addition within the next year. The company's strategic compelling opportunity for investors looking to
to any investment portfolio. focus on expanding its electric vehicle (EV) line- diversify their portfolios.
Hindustan Unilever Limited Market up positions it well in the rapidly evolving auto- CrudeOil Market Update :
Update : Hindustan Unilever Ltd (HUL) is a motive landscape. With strong sales in both Crude oil is currently trading at around Rs.
leading player in the FMCG sector, known for its passenger and commercial vehicles, along with 5,900, with potential to rise to Rs. 8,800 over the
extensive portfolio of trusted brands. Currently a commitment to innovation and sustainability, next year. The outlook is buoyed by ongoing
trading at around Rs. 2700, the stock is antici- Tata Motors stands out as a top choice in the market uncertainties, particularly geopolitical
pated to grow to approximately Rs. 3900 over auto industry. This combination of growth tensions in various regions, which are likely to
the next year, fueled by strong demand, strate- potential and diversification into EVs makes it drive prices higher. With a projected upside of
gic brand acquisitions, and innovative product an excellent addition to investment portfolios approximately 49%, crude oil remains a key
launches. HUL's focus on sustainability and dig- for both long-term and short-term investors. focus for investors. Factors such as supply chain
ital transformation enhances its competitive Vedanta Market Update : Vedanta Ltd disruptions and fluctuating demand further
edge. As a well-established company with con- (VEDL) is a prominent player in the steel and contribute to this bullish sentiment. As global
sistent financial performance, HUL is an excel- metal industry, currently trading at Rs. 470. markets respond to these dynamics, crude oil
lent choice for both long-term and short-term Analysts project significant growth, with poten- could present lucrative opportunities for those
investors, making it a valuable addition to any tial to reach Rs. 750 within the next year, driven looking to capitalize on its volatility.
portfolio. by rising demand for metals, operational effi- Copper Market Update : Copper is current-
Divis Lab Market Update : ciencies, and strong commodity prices. ly trading at Rs. 810, with a promising outlook
Divi's Laboratories (DivisLab) is a leading Vedanta's diverse portfolio, which includes zinc, for significant upside in the coming year.
player in the pharmaceutical industry, specializ- aluminum, and copper, positions it well to cap- Increased demand and decreasing supplies are
ing in active pharmaceutical ingredients (APIs) italize on global market trends. With solid fun- expected to drive prices higher, particularly if
and contract manufacturing. Currently trading damentals and a commitment to sustainable China's stimulus package is implemented,
at around Rs. 5870, analysts project the stock practices, Vedanta is considered a strong addi- which would likely boost industrial activity and
could rise to approximately Rs. 7440 over the tion to investment portfolios, making it an infrastructure projects. Analysts anticipate an
next year, driven by strong demand in both appealing option for both long-term and short- upside of around 22%, potentially reaching Rs.
domestic and international markets, ongoing term investors in the metal sector. 1,000. This bullish sentiment is further support-
R&D investments, and a robust pipeline of Wipro Market Update : Wipro Ltd is a lead- ed by the growing emphasis on renewable
products. With a solid track record of revenue ing IT services company currently trading at Rs. energy and electric vehicles, both of which rely
growth and profitability, DivisLab is considered 540, with growth potential projected to reach heavily on copper. As such, investing in copper
a top pick for investors looking to add a strong Rs. 980 over the next year. The recent could present a compelling opportunity for
pharma stock to their portfolios, making it a announcement of a 1:1 bonus share is likely to those looking to capitalize on favorable market
compelling choice for both long-term and boost investor sentiment and enhance liquidity. conditions in the year ahead.
SINCE 1992
DEEPOTSAVI ISSUE
14 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
15 BLUECHIP INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
stake. Hulst sold off its entire stake by September 30, 2023.
continue from previous page Business Profile: Coforge Ltd. operates as an IT solutions provider
subsidiaries in various countries including Canada, UK, Belgium, with a focus on digital transformation and technology services. Its busi-
Germany, Italy, Ireland, Spain, USA, Mexico, Brazil, China, Japan, ness model revolves around offering consulting, implementation, and
Singapore support services in areas such as cloud computing, cybersecurity, ana-
Key Business Developments: - lytics, and enterprise applications.
* Boston based Bank has chosen ADSL to provide Managed service Products & Services: The company provides solutions in product
for their Bank and customer field services support. engineering, digital solutions, data analytics, artificial
* Subsidiary of BP America, focused on oil and Natural gas explo- intelligence/machine learning (AI/ML), cloud, business process re-engi-
ration and production in Texas, has participated with ADSL. neering, digital process automation, and Low Code/No Code platforms.
* ADSL received Rs 190 Crores worth orders for the Taluja Smart Revenue Split:
Industrial city solutions Project in NAVI MUMBAI. By Geography- The co. operates out of 21 countries, with 26 deliv-
* ADSL was selected as a master system Integrator for the integration ery centres.
of CCTV surveillance with Existing ITMS control Room for the Ayodhya US: 48% in FY24 vs ~52% in FY22
Smart city project. EMEA & Africa: ~40% in FY24 vs ~36% in FY22
* Recently on 8th October company won an order worth Rs 430+ Cr Asia Pacific: ~7% in FY24 vs 8% in FY22
for Pune Safe City. India: 5% in FY24 vs 4% in FY22
Concall Notes August 2024 (Highlights): - By vertical-
* Completed 12 smart city projects with 2 new wins. BFS: 32% in FY24 vs 26% in FY22
* Management aims to reach mid-teens in EBITDA margins within the Insurance: 22% in FY24 vs 28% in FY22
next 3-4 quarters, with a long-term goal of achieving 18-20% margins. Travel, transport, and logistics: 18% in FY24 vs 19% in FY22
* There are 106 smart cities identified by the Government of India out Manufacturing and others: ~28% in FY24 vs 27% in FY22
of 22 have been implemented and out of 12 are with ADSL so this Service Mix-
speaks potential & opportunity. - Intelligent Automation: 11% in FY24 vs 14% in FY22
-ADSL have renewed several contracts in several sectors including IT * Data & Integration: ~25% in FY24 vs 21% in FY22
Consultancy, Defence & Space, Financial sectors, FMCG, Shipping. - Product engineering: ~9% in FY24 vs 12% in FY22
* ADSL, we are recently bidding for the Metro Project as well, doing - BPM: 9% in FY24 vs 11% in FY22
a CCTV setup at the Metro Railway Station. - CIMS: 19% in FY24 vs 18% in FY22
Future Projections: - - ADM (Software Engineering): ~27% in FY24 vs 25% in FY22
* Targeting revenue of ?1,000 crore by FY2027, with expectations to Order Book: As of FY24, the Co. has an order book of US$ ~1,900
achieve quarterly revenues nearing ?200 crore Mn.
* Expecting an opportunity size of Rs 50,000 Crore in the smart city Clients: The co. serves 61+ Forbes Global 1000 clients. As of FY24,
projects in next 5 years. Top 5 clients contribute ~23% and Top 10 clients contribute ~34% of
Conclusion: - the aggregate revenue.
The management expresses confidence in the company's growth tra- Strategic Partnerships:
jectory, driven by strong market demand, strategic initiatives, and an The co. has a partnership network with software providers such as
Microsoft, AWS, Google, Pegasystems, Appian, Salesforce, ServiceNow,
and Duck Creek. In May 2024, the co. announced a strategic partner-
ship with Fiorano to introduce ISO 20022 Compliance as a Service. In
March 2024, it also announced its multi-year strategic partnership with
Carnival UK, for precision quality engineering & testing.
New Projects: During Q4 FY24, the co. signed two large deals. A
$400 million TCV ten-year deal in the BFS vertical and a $55 million
three-year transformation deal in the insurance vertical with a new
client.
Acquisition of Cigniti Technologies: In May 2024, The co. signed a
definitive SPA to take over a 54% stake in Cigniti Technologies Ltd., for
Rs. ~2000 Cr. The co. believes this acquisition will help it to grow into a
$2 billion firm by FY27 and create three new scaled-up verticals - Retail,
Technology, and Healthcare.
Fund Raising: In May 2024, the co. allotted 48.6 Lakh Equity Shares
Rs. 4,600 per Equity Share through qualified institutional placement.
expanding pipeline of opportunities. Focus: The co. plans on transforming the legacy ADM service line
OUR THIRD DIWALI PICK - 2024 into a product engineering focus capability. It aims at rapid expansion
STOCK NAME - COFORGE LTD in North America, the Cigniti acquisition will expand North America
About: Coforge is an IT services company providing end-to-end soft- revenue by ~33%.
ware solutions and services. . It is among the top-20 Indian software OUR FORTH DIWALI PICK - 2024
exporters. Prominent global customers include British Airways, the ING STOCK NAME - MPHASIS LTD
group, SEI Investments, Sabre, and SITA. Over the years, Coforge has set About: Mphasis a global Information Technology (IT) solutions
up subsidiaries in the US, Singapore, Australia, UK, Germany and provider specializing in providing cloud and cognitive services, applies
Thailand, mainly to market and mobilise projects for the software divi- next-generation technology to help enterprises transform businesses
sion. The company has business partnerships with large IT companies globally.
across the world. Key Points: History: In June 2006, Electronic Data Systems
Key Points: Acquisition of NIIT Tech: NIIT Technologies Ltd., now Corporation acquired Mphasis, and later Electronic Data Systems
known as Coforge, was founded in April 2003. In 2019, NIIT and its Corporation (EDS) was acquired by Hewlett-Packard (HP), resulting in
founder's family sold their 30.2% stake to Hulst B.V., which subsequent- Mphasis becoming a 60.47% subsidiary of HP. However, in September
ly acquired an additional ~40% through an open offer, reaching a 70% continue on next page
SINCE 1992
DEEPOTSAVI ISSUE
21 BLUECHIP INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
continue from previous page Indicated (OAI) from over 44 USFDA inspections and overall 350+ reg-
Geographical Revenue Split FY24: ulatory inspections and ~125 customer audits since FY12.
North America - 41% Europe - 25% M&A: The company has integrated 15 mergers and acquisitions in
Japan - 4% India - 20% Others - 10% last 10 yrs.
The company has its presence in 100+ countries. Change in KMP: Mr. Nitish Bajaj, CEO of the ICH segment resigned
Expansion: The company has opened a new ADC manufacturing in Oct,24. Mr. Sarosh Shetty will replace him.
facility at Grangemouth which will commission in Feb,24. Aim: Company aims to be a Global Pharma, Health & Wellness
JV with Abbvie: The company owns 49% stake in the joint venture Company by FY30 with a revenue of $2 bn.
with Allergan India Pvt. Ltd (51% stake held by US pharma major 6) TECHMAHINDRA: 1735 SUPPORT: 1685-1630-1580
Abbvie) which is a leader in Opthalmology formulations in the Indian TARGET: 2100-2400
market. It has a strong presence in glaucoma, dry eye, infections and 7) ABSLAMC: 740 SUPPORT: 700-630 TARGET: 1000-1350
inflammation. 8) JYOTHYLAB: 510 SUPPORT: 440-380 TARGET: 830-1000
Key Brands - Refresh, Ozurdex, Combigan, Lumigan, Alphagan, 9) PROTEAN: 1820 SUPPORT: 1720-1620 TARGET: 2300-2700
Predforte. Products for this JV is manufactured at Piramal Pharma facil- 10) DIVISLAB: 5700 SUPPORT: 5500-5300 TARGET: 6500-6800
ity in Pithampur, India 11) ICICIBANK: 1250 SUPPORT: 1150-1080 TARGET: 1500-1800
Strategic Stake in Yapan Bio Ltd: 12) POLYMED: 2570 SUPPORT: 2500-2350 TARGET: 2900-3300
Piramal pharma holds a 33.33% stake in Hyderbad based Yapan Bio 13) WHIRLPOOL: 2240 SUPPORT: 2160-2050 TARGET: 2700-3000
which will help expand its CDMO footprint in biologics. Yapan Bio pro- 14) EMMBI: 140 SUPPORT: 110-80 TARGET: 280-380
vide process development, scale-up, cGMP compliant manufacturing of 15) VISHNU CHEMICALS: 490 SUPPORT: 450-380 TARGET: 750-1000
vaccines and biologics/bio-therapuetics. Yapan Bio's turnover was 11.8 16) MFSL: 1290 SUPPORT: 1190-1080 TARGET: 1500-1700
Cr for H1FY22. 17) PAYTM: 780 SUPPORT: 680-580 TARGET: 1100-1500
The company has 15 manufacturing sites, presence in 100+ coun- 18) OLECTRA: 1670 SUPPORT: 1570-1430 TARGET: 1980-2200
tries. 68% of revenues (FY22) are derived from regulated markets (NA 19) SILINV: 700 SUPPORT: 600-530 TARGET: 1000-1370
41%, Europe 23%, Japan 4%) while rest from India (22%) and others 20) PENIND: 195 SUPPORT: 150-110 TARGET: 280-400
(10%) 21) RGL: 170 SUPPORT: 130-80 TARGET: 290-380
Expansion: The company is planning for capacity expansion at the 22) NITCOLTD: 110 SUPPORT: 80-60 TARGET: 230-310
PPS Facility at Lexington, Kentucky. $80M investment plan will add 23) PRIMESECU: 315 SUPPORT: 280-230 TARGET: 500-630
commercial scale sterile injectables capabilities. 24) WOCKPHARMA: 1124 SUPPORT: 1050-980 TARGET: 1400-1730
Quality Focused: 25) RADICO: 2280 SUPPORT: 2180-2030 TARGET: 2500-2700
The company has a strong focus on Quality Control with 1000+ 26) CARTRADE: 980 SUPPORT: 900-830 TARGET: 1350-1500
resources in the quality function and has achieved Zero Official Action 27) HCLTECH: 1845 SUPPORT: 1780-1710 TARGET: 2100-2400
SINCE 1992
DEEPOTSAVI ISSUE
23 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
24 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
25 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
26 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
27 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
28 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
29 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
30 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
31 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
32 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
33 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
34 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
35 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
36 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
37 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
38 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024
SINCE 1992
DEEPOTSAVI ISSUE
39 BLUECHIP
INVESTMENTS
SAMVAT 2081 YEAR : 33 | ISSUE NO. 1&2 | 27 OCT TO 10 NOV 2024